Sulfur-based inhibitors for matrix metalloproteinases.

Sulfur-based inhibitors for matrix metalloproteinases. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Sulfur-based inhibitors for matrix metalloproteinases. Abstract Text:

Sulfur-based inhibitors for matrix metalloproteinases. Publishing Authors By Initials

For similar inorganic chemicals: elements: chalcogens: sulfur research abstracts see: inorganic chemicals: elements: chalcogens: sulfur research

PUBMED ID PMID:

MEDLINE DATE:

Sulfur-based inhibitors for matrix metalloproteinases. Journal Published:

PUBLICATION TYPE: Research Support, U.S. Gov't,

Journal: Matrix (Stuttgart, Germany). Supplement

VOLUME: 1

Page Numbers: 309-10

Journal Abbreviation:

ISSN: 0940-1199

DAY: 26

MONTH: 02

YEAR: 1992

Sulfur-based inhibitors for matrix metalloproteinases. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 9312140

Sulfur-based inhibitors for matrix metalloproteinases. Keywords Mesh Terms:

KEYWORDS: Sulfur

MESH TERMS: pharmacology

Chemical & Substance for Abstract: Sulfur-based inhibitors for matrix metalloproteinases. Information

Substance Name: Metalloendopeptidases

Registry Number: EC 3.4.24.-

Grant and Affiliation Information for Sulfur-based inhibitors for matrix metalloproteinases.

AFFILIATION: Department of Chemistry, Florida State University, Tallahassee 32306.

Country: GERMANY

AGENCY: United States NIDCR

GRANT: DE09122

ACRONYM: DE

MEDLINETA: Matrix Suppl

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Sulfur-based inhibitors for matrix metalloproteinases Related Publications

• A Mr 21,000 inhibitor of matrix metalloproteinases from human fibroblasts.
• Eosin staining of gelatine.
• Localization of cleavage sites for human fibroblast collagenase in the bait region of five mammalian alpha-macroglobulins.
• Matrix metalloproteinases.
• Matrix metalloproteinases.
• Mr 95,000 metalloproteinase produced by rat mammary epithelial cells.
• Strategies for production of inhibitory monoclonal antibodies against matrix-degrading proteinases.
• Sulfur-based inhibitors for matrix metalloproteinases.
• The latency of the human fibroblast collagenase precursor depends on an internal cysteine residue.